AVS Pulse Revenue and Competitors

Detroit, MI USA

Location

#1338

Growjo Ranking

Medical

Industry

Estimated Revenue & Valuation

  • AVS Pulse's estimated annual revenue is currently $8.5M per year.(i)
  • AVS Pulse's estimated revenue per employee is $257,939

Employee Data

  • AVS Pulse has 33 Employees.(i)
  • AVS Pulse grew their employee count by 38% last year.

AVS Pulse's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Co-Founder & Chief Technology OfficerReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Chief Operations OfficerReveal Email/Phone
5
Co-Founder & InventorReveal Email/Phone
6
VP People, Marketing and AdministrationReveal Email/Phone
7
Manager Clinical AffairsReveal Email/Phone
8
Regulatory and Quality LeadReveal Email/Phone
9
Executive ChairmanReveal Email/Phone
10
Corporate ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.5M3124%N/AN/A
#2
$57M13623%N/AN/A
#3
$7.5M94-18%N/AN/A
#4
$11.5M3841%N/AN/A
#5
$15M4442%N/AN/A
#6
$1.7M26-16%N/AN/A
#7
$9.5M3148%N/AN/A
#8
$18.7M5528%N/AN/A
#9
$3.5M7120%N/AN/A
#10
$7.5M1616%N/AN/A
Add Company

What Is AVS Pulse?

AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. To learn more about pulsatile intravascular lithotripsy, visit www.avspulse.com.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$8.5M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M33-3%N/A
#2
$9.3M3338%N/A
#3
$2.7M3310%N/A
#4
$8.7M333%N/A
#5
$3.8M33-17%N/A